Comparison

ALIGN TECHNOLOGY INC (ALGN) vs Edwards Lifesciences Corp (EW)

The same filed metrics for both companies, side by side.

What each names as a risk in its own annual report, how each is priced against its own history, and the tracked managers whose latest 13F reports a position in both.

Financials

ALGN

ALIGN TECHNOLOGY INC

Medical Devices

Revenue, FY25: $4.03B
Net income: $410M
Operating cash flow: $593M
Free cash flow: $491M
Net margin: 10.17%
Operating margin: 13.53%
Gross margin: 67.19%

Edwards Lifesciences Corp

Medical Devices

Revenue, FY25: $6.07B
Net income: $1.07B
Operating cash flow: $1.6B
Free cash flow: $1.34B
Net margin: 17.62%
Operating margin: 20.84%
Gross margin: 78.01%

Head-to-head

Filed growth, quality and valuation, read against each company’s own history rather than against the other side.

Metric	ALGN	EW
Revenue growth, latest filed year	+0.90%	+11.55%
Piotroski F-score	6 of 8	6 of 9
P/E against its own history	37.50% below	27.39% above

What each says it is exposed to

From Item 1A of each company’s most recent 10-K.

ALGN

Cybersecurity
Litigation
Tax
Currency moves
Supply chain
Tariffs

And 21 more.

FDA approval
Litigation
Reimbursement
Tariffs
Product recalls
Cybersecurity

And 13 more.

Tracked managers holding both

Joel Greenblatt Gotham Asset Management 0.07% · 0.02%

Updated Aug 31, 2026 · the newer of the two companies' filings